Voloridge Investment Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-69,114
| Closed | -$259K | – | 1335 |
|
|
2024
Q1 | $259K | Buy |
+69,114
| New | +$259K | ﹤0.01% | 1093 |
|
|
2023
Q4 | – | Sell |
-386,690
| Closed | -$3.23M | – | 1391 |
|
|
2023
Q3 | $3.23M | Sell |
386,690
-563,774
| -59% | -$4.71M | 0.02% | 788 |
|
|
2023
Q2 | $12.6M | Sell |
950,464
-764,942
| -45% | -$10.2M | 0.06% | 402 |
|
|
2023
Q1 | $19.9M | Buy |
1,715,406
+1,523,472
| +794% | +$17.6M | 0.1% | 281 |
|
|
2022
Q4 | $1.57M | Buy |
+191,934
| New | +$1.57M | 0.01% | 1033 |
|
|
2022
Q3 | – | Sell |
-220,926
| Closed | -$976K | – | 1570 |
|
|
2022
Q2 | $976K | Sell |
220,926
-625,254
| -74% | -$2.76M | 0.01% | 1197 |
|
|
2022
Q1 | $7.7M | Buy |
+846,180
| New | +$7.7M | 0.04% | 494 |
|
|
2020
Q4 | – | Sell |
-539,897
| Closed | -$5.33M | – | 1505 |
|
|
2020
Q3 | $5.33M | Buy |
+539,897
| New | +$5.33M | 0.04% | 429 |
|
|
2019
Q3 | – | Sell |
-12,873
| Closed | -$78K | – | 1185 |
|
|
2019
Q2 | $78K | Sell |
12,873
-5,603
| -30% | -$34K | ﹤0.01% | 720 |
|
|
2019
Q1 | $134K | Buy |
+18,476
| New | +$134K | ﹤0.01% | 905 |
|